Data is not available at this time.
Elion Energy Company Limited operates as a diversified chemical manufacturer and distributor in China, primarily serving the healthcare sector through specialty and generic drug manufacturing inputs. The company's core revenue model centers on producing and selling essential chemical products including polyvinyl chloride, caustic soda, ethylene glycol, methanol, and compound fertilizers that serve critical applications across chemical, light industry, building materials, agriculture, and pharmaceutical sectors. Beyond traditional chemical manufacturing, Elion has strategically expanded into clean energy and environmental protection businesses, positioning itself at the intersection of industrial chemicals and sustainable solutions. This dual focus allows the company to leverage its chemical expertise while capitalizing on China's growing emphasis on environmental sustainability and energy transition. Operating from its Beijing headquarters, Elion maintains a significant presence in China's industrial chemical landscape, though it faces intense competition in both traditional chemical markets and emerging clean technology sectors.
The company generated CNY 8.76 billion in revenue for FY 2023 but reported a significant net loss of CNY 541.8 million, indicating substantial profitability challenges. Despite the negative bottom line, operating cash flow remained positive at CNY 1.21 billion, suggesting some operational efficiency in cash generation. The negative EPS of CNY -0.15 reflects the overall unprofitability during this period, likely impacted by market conditions or operational inefficiencies.
Elion's earnings power appears constrained given the substantial net loss position, though the positive operating cash flow indicates some underlying business strength. Capital expenditures of CNY 975.9 million represent significant investment in maintaining or expanding operations, potentially focused on both traditional chemical production and newer clean energy initiatives. The disparity between negative earnings and positive operating cash flow suggests non-cash charges affecting profitability.
The company maintains a strong liquidity position with CNY 3.91 billion in cash and equivalents, providing a substantial buffer against operational challenges. However, total debt of CNY 5.48 billion indicates significant leverage, though the cash position partially mitigates this risk. The balance sheet structure suggests a company navigating transition while maintaining adequate short-term financial flexibility.
Despite profitability challenges, Elion maintained a dividend payment of CNY 0.02 per share, indicating management's commitment to shareholder returns. The company's strategic focus on clean energy and environmental protection represents a growth vector, though current financial performance suggests transitional headwinds. The dividend policy appears conservative relative to the company's earnings capacity.
With a market capitalization of approximately CNY 1.35 billion, the market appears to be discounting the company's prospects significantly relative to its revenue base. The low beta of 0.492 suggests the stock is less volatile than the broader market, potentially reflecting its defensive characteristics or market skepticism about growth prospects. The valuation likely incorporates expectations of continued challenges in achieving sustainable profitability.
Elion's strategic advantages include its diversified chemical product portfolio and early positioning in clean energy transition markets within China. The company's Beijing base provides proximity to policy makers and potential government support for environmental initiatives. The outlook remains challenging given current profitability issues, though the clean energy focus aligns with national strategic priorities that could drive long-term opportunities if successfully executed.
Company financial statementsShanghai Stock Exchange disclosuresMarket data providers
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |